You are here

  • Home
  • Archive
  • Volume 95, Issue 23
  • Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents

Article Text

Article menu

Download PDFPDF

Original article
Interventional cardiology
Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
  1. J-S Kim1,
  2. I-K Jang2,
  3. J-S Kim1,
  4. T H Kim1,
  5. M Takano3,
  6. T Kume4,
  7. N W Hur5,
  8. Y-G Ko1,
  9. D Choi1,
  10. M-K Hong1,
  11. Y Jang1
  1. 1
    Division of Cardiology, Yonsei Cardiovascular Centre, Yonsei University College of Medicine, Seoul, Korea
  2. 2
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
  3. 3
    Divison of Cardiology, Nippon Medical School, Tokyo, Japan
  4. 4
    Department of Cardiology, Kawasaki Medical School, Kurashiki, Japan
  5. 5
    Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
  1. Correspondence to Dr Y Jang, Division of Cardiology, Yonsei Cardiovascular Centre, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, 120-752 Seoul, Korea; jangys1212{at}yuhs.ac

Abstract

Objective: To evaluate the vascular response at 9 months after zotarolimus-eluting stent (ZES; Endeavor) implantation using optical coherence tomography (OCT). These findings were compared with those after implantation of a sirolimus-eluting stent (SES; Cypher Select).

Design: Cross-sectional observational study with prospective OCT registry.

Setting: Nine months after ZES or SES implantation.

Patients and methods: A total of 68 patients (32 ZES and 36 SES) underwent OCT at 9 months after stent implantation. The neointima hyperplasia (NIH) thickness inside each strut and percentage of NIH area at every 1 mm cross section were measured.

Main outcome measurement: The degree of neointimal coverage and the prevalence of malapposition at 9 months after ZES and SES implantation using OCT.

Results: The mean (SD) NIH thickness (251.2 (110.0) μm vs 85.5 (53.3) μm, p<0.001) and percentage of NIH area (27.9 (9.1)% vs 11.2 (7.1)%, p<0.001) were significantly greater in ZES than in SES. The prevalence of uncovered strut as well as malapposed strut was significantly lower in ZES than in SES (0.3% vs 12.3%, p<0.001 and 0.08% vs 2.6%, p<0.001). Thrombus was not observed in ZES (0.0% in ZES vs 27.8% in SES, p = 0.001).

Conclusions: Neointimal coverage in ZES was almost complete and malapposition was very rare at 9-months’ follow-up.

https://doi.org/10.1136/hrt.2009.167759

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding This study was supported by a faculty research grant from the Department of Internal Medicine, Yonsei University College of Medicine, 2008 and by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. (No A085012).

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • See Editorial, p 1895

    • Ethics approval Ethics committee approval from Severance IRB.

    Linked Articles